These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 32310027

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM, Park DW, Lee CW, Chang M, Cavalcante R, Sotomi Y, Onuma Y, Tenekecioglu E, Han M, Lee PH, Kang SJ, Lee SW, Kim YH, Park SW, Serruys PW, Park SJ.
    JACC Cardiovasc Interv; 2017 Jul 24; 10(14):1415-1424. PubMed ID: 28728654
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y, Cavalcante R, van Klaveren D, Ahn JM, Lee CW, de Winter RJ, Wykrzykowska JJ, Onuma Y, Steyerberg EW, Park SJ, Serruys PW.
    JACC Cardiovasc Interv; 2016 Aug 08; 9(15):1564-72. PubMed ID: 27491605
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials.
    Nerlekar N, Ha FJ, Verma KP, Bennett MR, Cameron JD, Meredith IT, Brown AJ.
    Circ Cardiovasc Interv; 2016 Dec 08; 9(12):. PubMed ID: 27899408
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW, Lee JM, Kang SH, Ahn HS, Kang HJ, Koo BK, Rhew JY, Hwang SH, Lee SY, Kang TS, Kwak CH, Hong BK, Yu CW, Seong IW, Ahn T, Lee HC, Lim SW, Kim HS.
    JACC Cardiovasc Interv; 2014 May 08; 7(5):471-81. PubMed ID: 24852802
    [Abstract] [Full Text] [Related]

  • 33. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
    Lee SW, Kim SH, Kim SO, Han S, Kim YH, Park DW, Kang SJ, Lee CW, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2012 Aug 01; 80(2):206-12. PubMed ID: 22234884
    [Abstract] [Full Text] [Related]

  • 34. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
    Diamond J, Madhavan MV, Sabik JF, Serruys PW, Kappetein AP, Leon MB, Taggart DP, Berland J, Morice MC, Gersh BJ, Kandzari DE, Dressler O, Stone GW.
    JACC Cardiovasc Interv; 2018 Dec 24; 11(24):2441-2450. PubMed ID: 30573053
    [Abstract] [Full Text] [Related]

  • 35. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL.
    N Engl J Med; 2015 Mar 26; 372(13):1213-22. PubMed ID: 25775087
    [Abstract] [Full Text] [Related]

  • 36. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.
    Giustino G, Serruys PW, Sabik JF, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Ragosta M, Kron IL, Liu Y, Zhang Z, McAndrew T, Dressler O, Généreux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW.
    JACC Cardiovasc Interv; 2020 Feb 10; 13(3):375-387. PubMed ID: 31954680
    [Abstract] [Full Text] [Related]

  • 37. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D, Colleran R, Cassese S, Frangieh AH, Wiebe J, Joner M, Schunkert H, Kastrati A, Byrne RA.
    JAMA Cardiol; 2017 Oct 01; 2(10):1079-1088. PubMed ID: 28903139
    [Abstract] [Full Text] [Related]

  • 38. Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
    Takagi H, Ando T, Umemoto T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group.
    Catheter Cardiovasc Interv; 2018 Mar 01; 91(4):697-709. PubMed ID: 28799701
    [Abstract] [Full Text] [Related]

  • 39. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH, Lee JY, Lee CW, Kim SO, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Park SJ.
    Circ Cardiovasc Interv; 2018 Jan 01; 11(1):e005374. PubMed ID: 29311287
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.